Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Miscellaneous | 10.87% |
| 5 | Consumer Discretionary | 10.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Domino's
DPZ
$11B
| $4.14M | 0.01% |
16,703
+6,699
| +67% | +$1.76M |
|
1702
NCR Voyix
VYX
$1.27B
| $4.13M | 0.01% |
291,943
+83,903
| +40% | +$1.32M |
|
1703
PUT
Freeport-McMoran
FCX
$113B
| $4.12M | 0.01% |
+400,000
| New | +$4.67M |
|
1704
G-III Apparel Group
GIII
$1.41B
| $4.11M | 0.01% |
147,490
-287,593
| -66% | -$10.6M |
|
|
ATRS
1705
DELISTED
Antares Pharma, Inc.
ATRS
| $4.1M | 0.01% |
1,507,964
+816,798
| +118% | +$2.69M |
|
1706
PUT
Texas Instruments
TXN
$243B
| $4.1M | 0.01% |
43,400
-111,700
| -72% | -$10.8M |
|
1707
CareDx
CDNA
$2.71B
| $4.1M | 0.01% |
163,023
+58,280
| +56% | +$1.5M |
|
|
ADMS
1708
DELISTED
Adamas Pharmaceuticals
ADMS
| $4.1M | 0.01% |
479,899
+229,404
| +92% | +$2.98M |
|
|
TVRD
1709
Tvardi Therapeutics
TVRD
$24.4M
| $4.09M | 0.01% |
8,732
-206
| -2% | -$133K |
|
1710
Southside Bancshares
SBSI
$951M
| $4.08M | 0.01% |
128,627
-239,046
| -65% | -$7.78M |
|
1711
Diageo
DEO
$51.2B
| $4.08M | 0.01% |
28,796
-42,401
| -60% | -$5.96M |
|
1712
CALL
Delta Air Lines
DAL
$53.4B
| $4.08M | 0.01% |
81,700
-98,200
| -55% | -$5.35M |
|
|
JHG
1713
DELISTED
Janus Henderson
JHG
| $4.07M | 0.01% |
196,597
-142,807
| -42% | -$3.28M |
|
1714
Resources Connection
RGP
$146M
| $4.07M | 0.01% |
286,610
+25,147
| +10% | +$407K |
|
1715
Intrepid Potash
IPI
$506M
| $4.06M | 0.01% |
156,295
+8,962
| +6% | +$308K |
|
1716
CALL
uniQure
QURE
$3.44B
| $4.04M | 0.01% |
140,100
+24,500
| +21% | +$682K |
|
|
TKKSU
1717
DELISTED
TKK Symphony Acquisition Corporation Unit
TKKSU
| $4.04M | 0.01% |
400,000
| – | – |
|
1718
Emerson Electric
EMR
$88B
| $4.03M | 0.01% |
67,396
+40,090
| +147% | +$2.7M |
|
1719
Catheter Precision
VTAK
$729K
| $4.01M | 0.01% |
+2
| New | +$4.71M |
|
1720
SPX Corp
SPXC
$10.3B
| $4M | 0.01% |
142,816
-36,218
| -20% | -$1.06M |
|
|
CFFAU
1721
DELISTED
CF Finance Acquisition Corp. Unit
CFFAU
| $4M | 0.01% |
+400,000
| New | +$4M |
|
1722
Harmony Gold Mining
HMY
$13.1B
| $3.98M | 0.01% |
+2,226,413
| New | +$3.91M |
|
1723
iShares US Aerospace & Defense ETF
ITA
$14B
| $3.98M | 0.01% |
+46,082
| New | +$4.44M |
|
1724
Standex International
SXI
$3.67B
| $3.98M | 0.01% |
59,225
+12,010
| +25% | +$1.01M |
|
1725
Loews
L
$22.5B
| $3.98M | 0.01% |
87,317
-337,587
| -79% | -$15.9M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $2.35B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.